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1. Introduction 
One of the main neurosurgical problem consists in accurately identify the margins of brain 
tumors to allow a tumor’s precise excision without destruction of the surrounding healthy 
tissue. Excision is optimal if the tumor mass is removed from the brain without affecting the 
surrounding healthy tissue or with minimum injury to it. The result of resection and the 
histopathological diagnosis of the extracted tumor tissue impose a therapeutic strategy to 
further treat the disease. Given these clinical requirements, it is highly recommended to 
accurately identify tumor tissue borders during the surgical operation proper, by means of 
specific methods and techniques. Identification is done in two steps: (a) a preoperative 
imaging of the tumor tissue and borders using CT, MRI, and/or ultrasound-based 
equipment; and (b) an intraoperative stage, in which the tumor borders are identified by 
direct visual inspection; the operating microscope, endoscopic techniques, and 
autofluorescence measurements of the tumor and healthy tissues are also available methods 
that may be associated with the visual observation/search. 
Laser-induced autofluorescence is one of the main candidates for use in the operative field 
to identify tumor borders in both benign and malignant cases. It may allow, in principle, 
accurate identification of the interface between normal brain tissue and tumor tissue by 
measuring the optical fluorescence spectra emitted by these tissues after excitation with 
laser optical beams having suitable characteristics. Literature reports show that the 
autofluorescence method is promising for delineating brain tumor resection margins 
(Bottirolli et al., 1998; Lin et al., 2000; Lin et al., 2001; Croce et al., 2003; Cubillos et al., 2006). 
At the same time, more research needs to be devoted in order to develop the instruments, 
procedures, and clinical recommendations for intraoperative use of autofluorescence, at the 
level of both in vivo and in vitro measurements (Kremer et al., 2009). 
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Literature reports also show that progress was made stepwise to identify brain tumor 
tissues and to differentiate them from the normal brain tissues on the base of the laser 
induced fluorescence emitted by exogenous fluorophores  (K. Svanberg and S. Svanberg 
1983, J. Ankerst et al.1984, S. Montan, K. Svanberg and S. Svanberg 1985, K. Svanberg 1986, 
Andersson – Engels et al. 1989, 1994). An alternative is the measurement of the 
autofluorescence emitted by the brain tissues, i.e. by the endogenous fluorophores  
contained naturally in them. The autofluorescence experiments were approached and are 
still developed along two main lines: the measurements of the spectral properties of the 
autofluorescence beams and the contemporary or consecutive measurements of the lifetime 
of the autofluorescence radiation (Andersson-Engels, et al. 1990a,b, Marcu et al. 2004, Butte 
et al. 2011). Combinations of these techniques reflected in imaging spectroscopy are also 
experimented (Gebhart et al. 2006, Kantelhardt  2007, Butte et al. 2010, Sun et al. 2010).   
This book chapter is conceived as a synthesis of the characteristics of the laser-induced 
autofluorescence method applied in neurosurgery for diagnostics and/or intraoperative 
procedures; at the same time relevant research contributions of the authors in this field are 
described in more detail and discussions are made on the place occupied by the 
autofluorescence method among the other methods/techniques used for real time 
differentiation between normal and tumor brain tissues.  
2. Materials and methods 
2.1 Autofluorescence definition: basic data 
The autofluorescence emitted by a tissue (in particular the brain tissue) is that fluorescence 
emitted by it when exogenous fluorescent substances are not added to it; in other words the 
autofluorescence radiation is emitted only by the natural constituents of the tissue when an 
optical radiation of suitable wavelength falls on the tissue. Consequently, autofluorescence 
spectra give accurate information about the content and molecular structure of the emitting 
tissue. The autofluorescence is emitted by molecules that exist normally in the tissues, 
following their resonant interaction with optical radiation. The scheme that describes the 
fluorescence emission and the lifetime of the fluorescence radiation emitted by a molecule 
(usually named fluorophore) is shown in Fig.1 (Danaila and Pascu, 2001; Valeur, 2001).   
The molecular de-excitation may also involve the energy transfer from an excited electronic 
singlet state to an excited triplet state by the process called “intersystem crossing”, one 
system being formed by the singlet and other by the triplet states (v=0 of S2 to v=4 of T2, or 
v=2 of S1 to v=0 of T2, or v=0 of S1 to v=4 of T1). The de-excitation of the molecule may be 
also produced without changing the electronic state by passing without emission of 
radiation from excited vibrational levels to less excited vibrational levels; this process being 
called vibrational relaxation and is accompanied by the slight heating of the samples.  
If the fluorophore interacts with an optical radiation emitted by an external light source in 
visible and/or ultraviolet, then the first process which takes place is the absorption of one 
(transition S0 to S1) or more (transition  S0 to S1 followed by  S1 to S2 etc) photons of this 
pumping radiation and the consequent excitation of the molecule due to the transition 
selection rules from the fundamental singlet  state S0 to the S1, S2,…Sn states; the time 
interval needed for that is one fsec i.e. the process is so fast that the excitation of the 
molecule takes place so quickly that the nuclei are found in the same position before and 
after the transition. Once excited on a vibrational (or rotational-vibrational) state of an 
excited singlet state, the molecule may pass to the fundamental singlet state on different 
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vibrational levels in different ways (Brewer et al., 2001). One  is the internal conversion on 
the S1 state which takes place in 10-6s – 10-12s followed by vibrational relaxation in 10-12s – 10-
13s on the v=0 vibrational level of the S1 excited singlet state. Both processes are nonradiative 
and the energy lost by the molecule is transformed in kinetic energy of it that may slightly 
increase the tissue temperature. From v=0 of S1 the molecule falls radiatively on several 
vibrational levels of the S0 state emitting fluorescence radiation in 10-6s – 10-9s. This is the 
main way in which the autofluorescence radiation is emitted, so that its characteristics such 
as wavelength, spectral range, time duration, polarization state are specific to the emitting 
molecules; i.e. the fluorescence radiation properties are related to the structural properties of 
the emitting molecules and with their environment which may influence the fluorescence 
emission. From the S1 state the fluorophore molecule may decay with a much lower 
probability back to the S0 fundamental singlet state by other mechanisms.  
 
 
 
Fig. 1. Molecular diagram used to describe the emission of fluorescence radiation 
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The molecule may pass from the S1 state to the first excited triplet state T1 by intersystem 
crossing in 10-4s – 10-13s; so, the molecule may occupy a vibrational level of a triplet state 
after which a vibrational relaxation may occur in 10-12s – 10-13s at the end of which v=0 on T1 
state is populated. The first triplet state T1 of the fluorophore molecule is metastable and 
consequently the lifetime of the molecule on it is much longer than on S1. From it there are 
two possibilities for the molecule to further de-excite.  One is the radiative transition on 
different vibrational levels of the fundamental singlet state S0 which leads to the emission of 
phosphorescence radiation at longer time intervals than the fluorescence radiation with 
respect to the time moment at which the S0 – Sn absorption occurs; usually, the 
phosphorescence takes place in 10-4s – 10-2s which is the lifetime of the molecule on the T1 
state. The phosphorescence radiation also differs from the autofluorescence by the 
wavelengths which are always longer in phosphorescence than in the fluorescence case. 
The second possibility to de-excite T1 to the S0 state is the intersystem crossing process 
(T1→S0) followed by fluorescence quenching which takes place in 10-11s–10-12s. The 
fluorescence quenching is, in fact, the process of vibrational relaxation which leads to the 
nonradiative decay of the molecule on v=0 belonging to the S0 singlet state.  
As a rule, the autofluorescence emission is produced after absorbing one photon of radiation 
at a wavelength which is usually in the near UV or in the short wavelengths range of the 
visible. Due to the fact that the fluorophore molecules are surrounded by the other tissues 
components, which normally (but not only) act as a liquid environment of the molecules, the 
rotational-vibrational levels are broadened on the singlet and triplet states so that the 
absorption and the fluorescence emission spectra are broad and their structures are also 
broadened. Consequently, in the autofluorescence spectra a partial superposition  between 
the emitted bands takes place but, nevertheless, the spectra characteristics are specific to the 
emitting molecules. At the same time, the fluorescence spectra (S1→S0 transitions) are more 
or less the mirror images of the corresponding absorption spectra. The pH of the tissue in 
which the emitting molecules are embedded may also influence the autofluorescence spectra 
characteristics, such as the spectral width, the shape etc. Some of the molecules found in the 
tissue alongside with the emitting fluorophores may absorb the emitted fluorescence; this 
leads to autofluorescence decrease and from here to errors in measuring/estimating the 
emitters’ positions and concentrations in the tissue. 
2.2 Autofluorescence experimental monitoring 
The experimental system for measuring autofluorescence signals should be conceived 
taking into account that fluorescence excitation is always produced at shorter wavelengths 
than is the emitted fluorescence radiation. At even longer wavelengths, 
autophosphorescence is emitted, with a lifetime longer than that of autofluorescence. The 
spectral distribution of the autofluorescence emission is much broader and more structured 
than that of the pumping/excitation radiation; at the same time its duration is usually 
longer than, and its polarization state is different from, that of the pumping beam. The 
coherence state of the excitation beam is different from that of the autofluorescence 
radiation. Experimentally, it is possible to excite autofluorescence using a laser beam that is 
monochromatic, coherent, and highly polarized. The obtained fluorescence radiation is 
incoherent, broad–band, and nonpolarized. 
Autofluorescence measures exclusively the properties of the tissues, because it is produced 
only by their endogenous molecules. It may provide, mainly, two types of information 
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(Sokolov et al., 2002): (a) image – allows obtaining a more or less extended image of a part of 
the studied tissue (Gebhart et al., 2006; Kantelhardt et al.,); and (b) fluorescence radiation – it 
is excited by focusing the pumping beam on the tissue (Lin et al., 2000, 2001, 2002; Kremer et 
al., 2009; Pascu et al., 2009). The fluorescence radiation has a spectral distribution and a 
specific intensity; it also has a polarization state, and is characterized by specific ratios 
between the spectrum peaks.  
Autofluorescence is highly sensitive to endogenous emitters of the tissue, if properly 
excited. It allows identification of the molecular components of a tissue and their 
combinations, and investigation of the interaction between them and the surrounding media 
(usually described by the pH of the tissue); it also allows the monitoring of the modifications 
produced in the molecular composition of a tissue by the effect of natural and/or artificial 
factors.  
The autofluorescence emission of a fluorophore may be characterized by the following 
properties (Pascu et al., 2009): overall intensity of the emitted spectrum; emission spectral 
range; spectral structure of the radiation described by the intensity peaks and their relative 
ratios and by the wavelength of the main intensity peak (if such peak exists); fluorescence 
lifetime, measured either by its full time width (FTW) or by the full time width at the half 
maximum of the fluorescence peak (FTWHM), if only one peak is involved (Yong et al., 
2006). 
The measurement of the lifetime requires excitation of the autofluorescence with a laser 
pulse that is short enough, i.e. it should have an FTWHM of 5 ns, at most. This parameter 
may be measured for each fluorescence peak if the autofluorescence spectrum exhibits more 
peaks.  
Human brain tissues (both normal and tumor) contain endogenous fluorophores that belong 
to the following classes of biomolecules: aminoacids (tryptophan, tyrosine, phenylalanine); 
structural proteins (collagen, elastin); enzymes and co-enzymes (flavin adenine dinucleotide 
- FAD, the reduced form of the nicotinamide adenine dinucleotiode-NADH, flavins); lipids 
(phospholipids, lipofuscin, ceroids); porphyrins; and vitamins (A, K, and D). The 
autofluorescence emitted by the tissue contains signals originating from the active 
fluorophores and depends on their concentration and spatial distribution, as well as the 
properties of the surrounding environment, such as pH, optical properties, structure and 
organization, homogeneity, (an)isotropy, and turbidity. 
The autofluorescence is, therefore, sensitive to the above mentioned properties, and may 
signal small modifications of any of them. Moreover, tissue histology and biochemistry 
leave their signatures on the autofluorescence spectra (Bottiroli et al., 1998; Toms et al., 
2005). Consequently, variations in the health state of the tissue that modifies its histology 
and/or histochemical properties can be evidenced by autofluorescence measurements. Such 
is the case of tumor/malignant tumor tissues that have properties that differ from those of a 
normal tissue; autofluorescence may become a method to detect and investigate malignant 
tumor tissues (Svanberg, 1987). 
In neurosurgery, it may assist the neurosurgeon to find, in real time, the borders of the 
malignant tumors. To do this, specialized equipment should be developed to detect the 
malignant tumors and/or their limits in the brain for early stages or more-developed tumor 
tissues. 
This article brings together the autofluorescence measurements made by the authors in 
brain tissues in view of future specific equipment development. 
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2.3 Sample preparation 
2.3.1 First type of sample preparation 
This approach was exploratory and it was chosen initially to find the best procedures for 
sample processing and for their mounting in the optical system. The conclusions that 
resulted from the measurements were used to identify the conditions for reproducibility in: 
sample preparation and arrangement in the optical set-up utilized for autofluorescence 
spectra excitation and collection. 
Accordingly, a protocol to conserve, transport, and treat tumor/normal tissues was 
established, to ensure unaltered samples. Once extracted using operative procedures, the 
brain tissue samples were kept immersed in natural saline at 20°C in a Dewar container. The 
time interval between tumor extraction and measurements was, at most, 60 min. The 
samples were irrigated from time to time with natural saline to prevent uncontrolled drying 
and to remove blood traces; the control and in any case the removal of the blood traces from 
the samples are important since blood fluorescence may superpose on the autofluorescence 
of the sample tissues (Andersson-Engels  et al., 1990a,b). The working temperature was 
20°C. To ensure the best possible conditions for reproducibility of the measurements and to 
prevent errors in the fluorescence excitation and collection, the samples were placed in 
direct contact with an optical quartz plate of 0.5 mm in thickness; each sample surface that 
was exposed to the excitation / fluorescence pumping radiation and from which the 
fluorescence was emitted was very well defined. The exposed surface was 1–2 mm in 
diameter (diameter of the excitation beam), and for each sample 5 such spots/discs were 
used in the measurements; the geometrical arrangement was reproducible, and the results 
obtained for each excitation wavelength were averaged. 
2.3.2 Homogenate preparation 
The results from the studies performed on samples processed as mentioned in the previous 
paragraph, have shown that there are variations in the reproducibility of the 
autofluorescence curves. To avoid this, samples were processed using a different method, 
namely, as homogenates: each sample was washed abundantly in natural saline, then 
ground and further exposed to ultra-sounds to obtain a homogeneous mixture. The 
preparing of the homogenates did not affect the molecular structures or concentrations of 
the constituent fluorophores in the samples. It was done to prevent errors due to the 
unhomogeneities occurring naturally in the collected samples and to the geometry at the 
interface between the tissue and the optical excitation/collection system. 
The optical arrangement for autofluorescence excitation/ collection was the same as 
described in the paragraph above. For each measured sample (either tumor or normal 
tissue), three measuring points/spots were used, and the three signals were averaged. The 
autofluorescence excitation and detection system worked for all samples within the same 
spectral range (excitation between 337 and 500 nm, and emission measurement between 400 
and 650 nm), so that no corrections related to variation in the sensitivity of the 
photodetectors with wavelength were needed from one sample to another. 
2.4 Experimental set-up and sequence 
The main goal of the measurements was to identify the spectral properties of the 
autofluorescence of brain tissues for two cases/types of samples: normal tissues and 
malignant tumor; by studying these spectra, one aimed to establish criteria to differentiate 
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between the fluorescence radiations emitted by the two types of samples and to quantify the 
differences between them. The experiments were made in two steps: (a) measurement of the 
spectral characteristics of the autofluorescence emitted by the fluorophores existing in the 
brain tissues; and (b) comparative in vitro measurements of the spectral properties of the 
autofluorescence emitted by pairs of normal/malignant tumor tissue. 
The experimental set-up (shown in Fig.2) consisted of a system adapted to measure laser-
induced fluorescence (LIF).  
In choosing the radiation source used to excite the autofluorescence, several variants 
previously reported in the literature were evaluated (Ramanujam et al., 1994; Ramanujam, 
2000; Lin et al., 2002; Wu et al., 2003).  
For the purpose of this work, a pulsed laser with emission in the near-ultraviolet and visible 
spectral ranges was developed. This has two advantages: (a) it generates short time-width 
laser pulses of relatively low energy, which produce a weak perturbation of the studied 
tissues and a higher overall efficiency of the fluorescence emission; and (b) it enables 
measurement not only of the spectral distribution of the autofluorescence radiation but also 
of the fluorescence emission lifetime. 
The laser source is a frequency-doubled tunable dye laser pumped by a nitrogen pulsed 
laser (NPL), described elsewhere (Danaila and Pascu, 1999; Pascu, 2000; Danaila and Pascu, 
2001). The main characteristics of the laser system unit used to pump the fluorescence are (a) 
NPL: emission at 337.1 nm, laser beam bandwidth < 0.1 nm, pulse FTW 1 ns, energy / pulse  
50 ǍJ, peak power per pulse 500 kW, pulse repetition rate continuously adjustable between 1 
and 10 pulses per second (pps), beam divergence 5 mrad x 10 mrad; and (b) tunable dye 
laser: NPL pumped, emits tunable radiation between 350 and 700 nm by using a succession 
of dyes, beam spectral bandwidth maximum 0.2 nm, pulse FTW 1 ns, energy per pulse 
typically 5 ǍJ, pulse repetition rate as driven by the NPL, and laser beam divergence 5 mrad. 
The dye laser beam focusing produces an irradiance of 108 W/m2 on the sample. The dyes 
that were mostly used in the experiments are given in Table 1.  
 
Laser dye Synonymous Chemical
formula 
Molec. 
weight
Solvent Molar 
concentration 
POPOP 2,2'-(1,4-phenylene)bis[5-
phenyl-oxazole] 
C24H16N2O2 364 toluene 3.510-3 
Coumarin 540A 
(Coumarin 153) 
2,3,6,7-tetrahydro-9-
(trifluoromethyl)-1H,5H,11H-
[1]benzopyrano[6,7,8-ij] 
quinolizin-11-one 
C16H14F3N
O2 
309.29 ethanol 510-3 
Rhodamine 590-Rh 
590 
(Rhodamine 6G-Rh 
6G) 
2-[6-(ethylamino)-3-
(ethylimino)-2,7-dimethyl-3H-
xanthen-9-yl]-benzoic acid, 
ethyl ester perchlorate 
C27H29ClN2
O7 
543.01 ethanol 510-3 
 
Table 1. Laser dyes used in the autofluorescence experiments 
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Fig. 2. The fluorescence/autofluorescence excitation set-up. 
The frequency doubling crystal used to cover by second harmonic generation (SHG) the 
wavelength gap in the near-ultraviolet up to 337.1 nm is an ADP crystal; the obtained laser 
beam has with the following characteristics: tunability range 260 – 300 nm, spectral 
bandwidth 0.05 nm when the pumping dye laser beam has 0.1 nm full spectral bandwidth, 
pulse FTW ≤ 1 ns, pulse repetition rate as driven by  the NPL, peak energy per pulse 
typically 0.5 ǍJ, which enables obtaining a peak irradiance of 5 x 106 W/m2 at the focus. The 
system to excite and collect the autofluorescence signal (Fig. 2) consisted of a pair of optical 
fibers, one of which is used to excite the autofluorescence; it transmits the excitation beam 
with losses lower than 1%. The excitation optical fiber is a quartz fiber with a core of 1.5 mm 
in diameter; it has a transmission spectral range between 180 and 700 nm, and a numerical 
aperture NA = 0.22. The fiber used for the collection of the autofluorescence signal is a fiber 
bundle of 6 mm in diameter, transmitting between 400 and 700 nm. The sample is either a 
solution or a piece of brain tissue prepared for in vitro measurements. The autofluorescence 
radiation transmitted by the collection optical fiber is focused on the input slit of a 
monochromator; this is part of the spectral analyzing unit, and works between 220 and 800 
nm at a linear dispersion of 0.4 nm/mm; signal detection is made by using a fast 
photomultiplier, sensitive between 180 and 800 nm and able to measure optical signals with 
rise times of up to 1 ns. With this system (Autofluorescence spectral analysis unit type 1 in 
Fig.2), the spectral distribution and the lifetime of the autofluorescence were measured. 
The second variant (Autofluorescence spectral analysis unit type 2 in Fig.2) for signal 
detection was a computer- controlled, 2048 pixel CCD camera working between 300 and 800 
nm, used only for spectral distribution measurements. 
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3. Results 
3.1 Fluorophore measurements 
The measured samples were primary endogenous fluorophores, such as aminoacids, 
structural proteins, enzymes and coenzymes, porphyrins, and riboflavins. Literature reports 
(for example Zuluaga et al., 1999; Drezek et al., 2001a, b) on the fluorescence properties of 
such fluorophores show sets of data measured in experimental conditions that differ slightly 
from one case to another; this prevents the construction of a reference system based on 
which the interpretation of the autofluorescence data measured in brain tissues could be 
made. In this chapter, are presented data measured on primary fluorophores that are 
potentially present in the brain tissues, aiming to have controllable comparison conditions 
for the autofluorescence measurements made on tissue samples. So, Figs. 3 – 5 show the 
fluorescence spectra of the, respectively, phenylalanine, tryptophan and tyrosine solutions 
are shown when excited at 266 nm.The samples for each substance were phosphate buffer 
aqueous solutions at pH = 7 and the concentrations were in each case 10-5M. 
 
 
Fig. 3. The phenyalanine fluorescence emission spectrum  
 
Fig. 4. The tryptophan fluorescence  emission spectrum. 
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Fig. 5. The tyrosine fluorescence emission spectrum 
The fluorescence peaks for each of these aminoacids are broad, have different  intensities, 
are unstructured and constitute a superposition of narrower peaks originating in transitions 
between several specific pairs of electronic states. To obtain an objective base for the 
autofluorescence spectra, the LIF was measured  for various fluorophores. Figs. 6–12 show 
fluorescence spectra emitted by fluorophores which are found in brain tissues as follows: in 
Fig.6 NADH  excited at 337.1 nm with NPL laser  beam; in Fig.7 and Fig.8 collagen excited at 
266 nm with beam obtained by SHG from Rh6G emission at 532 nm, respectively at 337.1 
nm; in Fig.9 elastin excited at 337.1 nm; in Fig.10  FMN (flavin mononucleotide) excited at 
337.1 nm;  in Fig.11 riboflavin excited at 440 nm; in Fig.12 protoporphyrin excited at 440 nm 
by laser beam emitted either by coumarine  or by POPOP. 
 
 
Fig. 6. Fluorescence emission of NADH 
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Fig. 7. Fluorescence emitted by collagen  excited at 266 nm   
 
Fig. 8. Fluorescence emission by collagen excited at 337.1nm  
 
Fig. 9. Fluorescence emitted by elastin  excited at 337.1 nm  
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Fig. 10. Fluorescence emitted by FMN  
  
Fig. 11. Fluorescence emission of riboflavin  
  
Fig. 12. Fluorescence emission of protoporphyrin  
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The results are given in Table 2, which shows the fluorescence peak positions, together with 
the corresponding excitation wavelengths. 
 
Compound Solvent / 
concentration 
Excitation wavelength (nm) / 
utilized laser 
Fluorescence 
wavelength 
peak 
Collagen 10-5M phosphate buffer 
aqueous solutions at pH = 7
270/SHG of dye laser at 540 nm 395 
Collagen 10-5M phosphate buffer 
aqueous solutions at pH = 7
285/SHG of dye laser at 570 nm 310 
Collagen 10-5M phosphate buffer 
aqueous solutions at pH = 7
337.1/NPL 395 
NADH 10-5M phosphate buffer 
aqueous solutions at pH = 7
290/SHG of dye laser at 580 nm 510 
NADH 10-5M phosphate buffer 
aqueous solutions at pH = 7
337.1/NPL 455 
NADH 10-5M phosphate buffer 
aqueous solutions at pH = 7
400/tunable dye laser (POPOP) 510 
Table 2. Fluorescence peaks of several fluorophores 
The lifetimes of the fluorescence radiation emitted by some fluorophores that are found in 
the brain tissues, measured as in Fig.2, are displayed in Table 3; most of the values are 
between 1ns and 10ns. As for NADH this value is very short and  a p-i-n (PIN) fast 
photodiode was used, which was able to indicate only that the fluorescence lifetime is 
shorter than 0.5 ns.  On the contrary for the FMN the lifetime is longer, around 45ns. 
These values may be used as discriminating factors between different types of tissues.   
 
Compound Fluorescence lifetime 
(FTWHM) ns 
Compound Fluorescence lifetime 
(FTWHM) ns 
Tryptophan 2.9 Collagen 5.5 
Tyrosine 4.1 Flavin monocleotide (FMN) 45 
Phenylalanine 6.0 Porphyrin 12 
NADH < 0.5   
Table 3. Fluorescence lifetimes for several brain tissue compounds 
The autofluorescence measurements performed on some of the main molecular components 
of the brain tissues allow to conclude as follows: (a) the autofluorescence spectra of the 
fluorophores strongly depend on the absorption characteristics of the fluorophores 
molecules, which–in turn–depend on the solvent, solution pH, and concentrations in the 
samples; this is a rather general conclusion in LIF but, in this case, it becomes particularly 
critical; (b) the fluorescence excitation and emission spectra are mainly obtained by 
excitation with laser radiation in the near-ultraviolet and visible (200–500 nm) and are 
emitted in the visible; (c) each of the fluorophore molecules has a specific fluorescence 
pattern/trace which depends on the excitation wavelength. The spectral distribution of the 
fluorescence radiation and the number, relative intensities and shapes of the peaks are 
strongly dependent on the excitation wavelength. For qualitative analysis, the use is 
www.intechopen.com
 Diagnostic Techniques and Surgical Management of Brain Tumors 
 
258 
recommended of more successive wavelengths in order to accurately identify the specific 
peaks for each fluorescence source; (d) if fluorescence peaks, that are very close to each other 
in the spectrum, are emitted by different fluorophores, one possibility to reveal the emitting 
molecules and to differentiate between them is to measure the fluorescence lifetime, which 
may differ from one fluorophore to another. 
3.2 Brain tissue measurements 
The data reported above can be used to reveal alterations of normal brain tissues towards 
tumor tissues (either benign or malignant). For such cases, the first factors to be considered 
are related to the interaction between the laser beam and the tissue on which it is falling 
(Pascu, 2000; Danaila and Pascu, 2001; Pascu et al., 2009). Figure 13 describes the processes 
of laser beam interaction with brain tissues which derive from the general case of the laser 
beam-target tissues interaction. At the point of contact with the tissue border (i.e. the 
interface of the tissue with the environment form which the laser beam comes), the laser 
beam (of intensity I0) is reflected in part (IR) and backscattered (Ib.s) by elastic scattering 
(Gong et al., 2008); a non-negligible part of it is sent back to the environment without 
interacting with the tissue. The beam penetrating the tissue is refracted (Ir), depending on 
the tissue’s optical properties and changes its propagation direction with respect to the 
incident beam. A part of it is scattered forward (If.s) the light spreading around the incidence 
point inside the tissue in all directions, function of the unhomogeneities of the tissue. 
Another part (Ia) is absorbed by resonant interaction. The rest (Irem) propagates further into 
the tissue. The energy balance is given by: 
I0 = IR + Ib.s. + Ir + If.s. + Ia + Irem. 
The equation above is approximate since it does not take into account the inelastic scattering 
of the laser light which may take place in the tissue; Ia describes not only the laser beam 
intensity absorbed along the main propagation line (which is mainly defined by the 
refracted beam direction) but also the absorption which takes place in all the tissue volume, 
scattered light included.     
Out of the mentioned intensities, Ia is responsible for the excitation of the autofluorescence 
radiation. At the wavelengths used in these studies, water and hemoglobin (two important 
components of brain tissues) do not interfere with the fluorescence emission process. Water 
is practically nonabsorbing in the visible and the near-ultraviolet absorption does not lead to 
fluorescence emission by water molecules.   
Hemoglobin does not absorb above 600 nm, and the strong absorption below 600 nm does 
not lead to significant fluorescence emission (hemoglobin fluoresces very weakly when 
excited below 300 nm, and the fluorescence lifetime is shorter than 25 ps). Even so, brain 
tissue samples not having blood within the structure (because they were abundantly 
washed with natural saline solution) were chosen for the study so that absorption of the 
laser beam due to hemoglobin in the samples was negligible. Autofluorescence of the tissue 
samples was excited at 337.1 nm and at longer wavelengths, up to 500 nm. 
These wavelengths are also recommended for in vitro measurements for other reasons: the 
depth of laser beam penetration in the tissue is much lower (one-two orders of magnitude) 
below 337 nm, the radiation at 337.1 nm and above this wavelength is more intense 
(typically one order of magnitude higher) than in the case of beams (available for these 
studies) emitted below 300 nm; in vivo interaction of the brain tissues with radiation below 
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300 nm may lead to undesirable effects on the cells, such as cleavage of molecular bonds 
(Lin et al., 2001).  
 
 
Fig. 13. Laser beam-tissue coupling processes 
The excitation at the mentioned wavelengths allows to include contributions to the 
autofluorescence spectrum of all the fluorophores contained in the brain tissues (Drezek et 
al., 2001a,b; Trujillo et al., 1998). Since in vitro measurements were made in brain tissue 
samples extracted under anesthesia, the fluorescence properties of the utilized anesthetics 
were considered as well.  The substances were sodium thiopental, fentanyl, pancuronium, 
suxamethonium, and sevoflurane. Following excitation, sodium thiopental, pancuronium, 
and fentanyl do not show fluorescence emission. Suxamethonium affects the tryptophan 
side-chain chromophores, and sevoflurane quenches tryptophan fluorescence and reversibly 
increases NADH fluorescence (Ramanujam et al., 1994; Utzinger et al., 1999). The anesthetics 
are distributed in both normal brain tissue and the tumor, so that their contribution to the 
autofluorescence spectrum may be detected in both cases. It might be that their 
concentration in the tumor is higher, in which case LIF signals would be stronger on the 
tumor side, so that the edge between the normal tissue and the tumor could be more 
precisely identified. 
The tumor samples used for in vitro measurements were extracted by neurosurgical 
operations performed according to current medical procedures. The normal tissue samples 
were taken (using standard procedures) from zones around nonruptured aneurisms that 
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had been operated to prevent accidental ruptures. The measurements were made in tissue 
samples extracted from different brain tumors. A set of tumors and their location in the 
brain as shown in the CT or MRI images are given in Figs. 14 - 17, which show the brain 
status before and after tumor extraction.  
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Fig. 14. A and B: Preoperative coronal and sagital T1-weight gadolinium-enhanced MRI, 
demonstrating of an anterior third ventricle tumor (astrocytoma); C and D: Images obtained 
after complete removal of the tumor making excision thorugh a midline transcallosal 
approach  (surgeon Leon Danaila). 
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A typical autofluorescence curve for a normal tissue excited at 337.1 nm is shown in Fig. 18, 
measured under the conditions specified in paragraph 2.3.2; the emission peak is located at 
460– 470 nm, and the curve shape shows a possible contribution of NADH, flavin, and 
porphyrin. Similar autofluorescence spectra were measured in different samples of normal 
brain tissue, excited at 337.1 nm. The curves are slightly different from each other, which 
show a relative variability and a low reproducibility of the autofluorescence signals from 
one patient to another. The differences may be due to the different optical properties of the 
tissues (the relative concentrations of the fluorophores in them, the pH, and the different 
homogeneity). The detailed studies of a large number of autofluorescence spectra of normal 
brain tissues excited in the visible and ultraviolet allow the conclusion that the 
autofluorescence of a brain tissue is not a mathematical sum of the contributions of the 
fluorophores existing in its structure, because (a) the autofluorescence peaks are quite broad, 
which makes it difficult to accurately estimate their wavelengths; (b) the different 
wavelengths to use for autofluorescence excitation (around 340 nm and particularly 337.1 
nm) are most recommended due to relatively deeper penetration of the radiation in the 
tissues and at these wavelengths most fluorophores yield marked fluorescence signals; and 
(c) spectra differ, although not dramatically, from one brain zone to another and from one 
patient to another, even under strictly reproducible experimental conditions. These 
conclusions suggest that in order to use LIF for distinguishing between normal brain and 
(malignant) tumor tissues in real-time neurosurgical operations, ‘‘in situ’’ measurements for 
normal/tumor tissue pairs should be made. This could enable a correct evaluation of the 
tumor boundaries with respect to the normal tissues for each specific case. 
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Fig. 15. A and B: Preoperative contrast –enhanced ,T1 –weighted, coronal and sagital MRI 
scan demonstrated hypointense sellar and suprasellar polycystic lesion a rim of cysts walls 
enhancement and a region of intracyst enhancement; C and D: T1-weighted coronal and 
surgical MRI after radical subfrontal resection (surgeon Leon Danaila).  
 
 
Fig. 16. Large left intraventricular astrocytoma. A: Preoperative contrass-enhanced coronal 
magnetic resonance imaging scan. B. Postoperative contrast-enhanced resonance imaging 
scan (surgeon Leon Danaila). 
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Fig. 17. Intraventricular astrocytoma. A: Preoperative contrast-enhanced axial CT scan 
demonstrates a heterogeneously enhancing tumor within the lateral ventricle. The patient 
underwent craniotomy and resection of this tumor through parieto-occipital approach. B: 
Postoperative CT scan demonstrates resection of the tumor (surgeon Leon Danaila).  
 
 
Fig. 18. The autofluorescence emission of a normal brain tissue excited at 337.1 nm. 
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Fig. 19. The autofluorescence emission of a healthy brain tissue and of a barin malignant 
tumor tissue  excited at 337.1 nm.  
3.3 Autofluorescence of normal/tumor brain tissue pairs 
Measurements were performed on several sample pairs (prepared as mentioned in the 2.3.2  
paragraph), each pair consisting of tumor tissue and normal tissue extracted from the same 
patient. The normal tissue samples were prelevated to avoid zones of brain compression by 
the tumor. In collecting the samples, different kinds of tumor were chosen, so that the nature 
of the tumor was not a criterion in selecting the tissues to analyze. Given the fluorophores 
present in the structure of the brain tissues, and their autofluorescence properties, three 
wavelengths were selected to excite the autofluorescence: 337.1, 370, and 410 nm. 
The measurements performed on homogenates showed that (a) the spectral distribution of 
the autofluorescence signals for a given homogenate is very close to that of the untreated 
sample and it is reproducible from one measurement to another; and (b) the 
autofluorescence spectra of the tumor samples are close to those of normal tissues, but the 
differences that do exist between them enable identification of the tumor and the normal 
tissue and consequently their differentiation. The main difference is that for each sample 
pair the peak autofluorescence spectrum for the normal tissue is shifted with respect to the 
tumor case. The overall intensity of the autofluorescence is also different for the components 
of the pair. As an example, Fig. 19 shows the autofluorescence of a normal sample excited at 
337.1 nm and the spectrum obtained under the same conditions for the tumor sample. 
Comparison of the two curves illustrates that the autofluorescence peaks are shifted by 15 
nm. The two autofluorescence peaks for the normal tissue are emitted at 390 and 450 nm, the 
intensity ratio being: R337normal =  I450 / I390 = 1.44; for the tumor sample, R337tumor =  I450 / I390 = 
1.31. Another parameter measured to individualize the autofluorescence curves is the 
overall intensity, defined as Ioverall = ∫I(ǌ). It is specific for each curve, and is a function of the 
pumping wavelength. For Fig. 19, I337normal = 18.298, respectively, I337tumor = 12.852. The 
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above-mentioned quantities (the peak intensity walk-off, the ratio between the main 
fluorescence peaks, and the overall autofluorescence intensity) may be used as objective 
parameters to differentiate between normal and tumor brain tissues. For excitation of the 
samples at 337.1 nm, these parameters differ from the normal to the tumor tissue by 15 nm 
peak intensity walk-off, 10% variation of the ratio of the peak intensities, and about 40% 
difference in the overall autofluorescence intensity. The same kind of measurement is made 
for samples excited at 370 nm. Figure 20 shows the autofluorescence spectra for the normal 
and tumor samples. The peak intensity ratios for 470 and 525 nm are R370normal = I470 / I525 = 
1.51; R370tumor = I470 / I525 = 2.09; the difference is about 40%. Thus, I370normal = 20.2 and I370tumor 
= 16.4, a difference of 23%. For the excitation at 410 nm, the obtained autofluorescence 
spectra are shown in Fig. 21; the respective parameters are R410normal = 1.45 and R410tumor = 
2.15, the difference being 40%; 
 
 
Fig. 20. The autofluorescence spectra for healthy and malignant tumor brain samples 
(excitation at 410 nm). 
I410normal = 10.52 and I410tumor = 16.125, the difference being 27%. 
Another parameter that may be used to distinguish between the normal and the tumor 
tissue is what we called  the quality factor of the fluorescence curve, Q, defined as the ratio 
between the maximum fluorescence intensity Imax and the difference of the two wavelengths 
where the fluorescence intensity reaches  half of its maximum value  (Imax/2): 
Q = Imax  /  (Imax/2)        
Calculating Q for the curves that represent the fluorescence emission of the two types of 
tissues at 337.1 nm excitation wavelength (Fig.19), the following values were respectively 
obtained: Q337norm = 0.99 and Q337tum = 0.67; these values of the  quality factor for the two 
tissue homogenates differ by about 30%, which qualifies this parameter as a good 
candidate to describe the spectral differences between the two types of tissue - normal 
and tumor. 
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Fig. 21. The autofluorescence spectra for healthy and malignant tumor brain samples 
(excitation at 370 nm). 
Given the fact that: 
i.  for measuring the pair of the two types of tissue homogenates precautions were taken 
to insure a reproducible measurement geometry, and   
ii. a calibration of the measuring system was performed for each sample measurement the 
idea of direct subtraction  of fluorescence intensity values of the two types of tissue at 
each wavelength is consistent and do not  produce systematic errors.  
The result of point by point subtraction of the two autofluorescence curves excited at 337.1 
nm shown in Fig.19 is presented as the Figure 22. 
 
 
Fig. 22. Difference in autofluorescence  spectra between tumor and normal tissue shown in 
Fig.19. ,Δ Fluorescence Intensity is given in arbitrary units and represents the difference 
between the autofluorescence signals for each wavelengths .  
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As results from the Fig. 22,  there are two spectral ranges, namely 385 – 415 nm and 460 – 
500 nm, within which the difference between the intensity of the fluorescence emitted by the 
two types of tissue is maximal. This shows the possibility to use this treatment procedure of 
the pairs of autofluorescence curves to spectrally evidence the difference between the 
normal and tumor tissue. The difference curve in Fig.22 shows two maxima,  at 386 nm and 
463 nm wavelengths, respectively. Moreover, at  = 386 nm the difference of the two 
intensities is 26% out of the peak of the fluorescence intensity (Fig.19) , while at  = 463 nm 
this difference reach even 41% (see Fig.19) , favoring this wavelength.  Similar results are 
obtained from homogenates at excitation wavelengths 370 nm and 410 nm (data not shown).  
A summary of all the parameters mentioned in this section (except the subtraction 
spectrum), computed from the autofluorescence curves  obtained  for the homogenates of 
the two types of tissue (normal and tumor) at each of the three excitation wavelengths used, 
is presented in  Table 4. 
 
Excitation 
Wavelength 
Tissue 
type 
Parameter 
  Ratio R Quality 
factor Q 
Overall 
intensity I 
Walk off of the 
autofluorescence 
peak (nm) 
337.1 nm normal 1.44 0.99 18.298  
15.0  tumor 1.31 0.67 12.852 
370 nm normal 1.51 1.26 20.2  
13.0  tumor 2.09 1.69 16.4 
410 nm normal 1.45 1.59 10.52  
3.0  tumor 2.15 1.60 16.125 
Table 4. Summary of the parameters used to differentiate between the normal and tumor 
tissue samples on the base of autofluorescence spectra  
In Table 4 are shown only the results obtained when the autofluorescence is excited, 
respectively, with 3 wavelengths: 337.1 nm (NPL), 370 nm (SHG starting form the 
fundamental beam at 540 nm) and 410 nm (POPOP). Of course, during the experiments and 
tests one may select other wavelengths, namely those that may provide the most important 
differences between the autofluorescence spectra excited for normal and corresponding 
tumor brain tissues. Although it appears that the type of tumor does not dramatically 
influence the measuring techniques, it remains that for each such type, a selection of the 
most suitable parameter to best monitor the differences is made.    
4. Discussion 
The reported data, correlated with literature reports (Hogan, 2008; Kremer et al., 2009) show 
that autofluorescence measurements may constitute a promising method to differentiate 
between brain tumor tissue and normal brain tissue in the same patient. 
In this paper it was demonstrated that by comparing the autofluorescence spectra induced 
by laser radiation in the ultraviolet and visible, brain tumor and normal tissues can be 
identified and differentiated. The recommended measurements were not performed on 
tissue samples kept as they were extracted from the brain, but on homogenates to ensure the 
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best possible reproducibility of the results. It was concluded that the autofluorescence 
spectra of the tumor samples are close to those obtained for normal tissues, but there are 
differences between them that allow distinguishing the tumor from normal tissue. 
One difference is that for each tumor/normal tissue sample pair the peak autofluorescence 
for the normal tissue is translated with respect to that for the tumor, typically between 10 
and 20 nm; the overall autofluorescence intensity is different for the components of the same 
pair, the difference being 15–30%. 
Another parameter that may be used is the variation of the ratio of some peaks of 
fluorescence intensity (which correspond to each other) between the normal and the tumor 
tissue samples. When this parameter can be measured, the variation range is usually 
between 10% and 40%.  
A specific factor that may be used to differentiate between normal and tumor brain tissues is 
the quality factor of the autofluorescence curves which may vary in the range 1 to 2 for 
normal tissues and from 0.5 to 1.6 for tumor tissues, function of the laser beam wavelength 
used to excite the fluorescence.   
As for the difference spectra obtained by subtracting the autoflorescence signals in the 
normal, respectively tumor case, the peaks which are obtained could be used to distinguish 
between to the types of tissues in real time; on the other hand, it remains to chose the most 
recommended wavelength to excite the fluorescence, so that the difference spectra exhibit 
the best resolution of the difference peaks.    
Another conclusion is that in vitro experiments show that for the measurements, it is 
mandatory to use normal /tumor tissue sample pairs taken from the same patient. In our 
case, for ethical considerations, the samples used were extracted from the brain during 
medically justified neurosurgical operations, in agreement with operative standards. For 
studies on normal tissues only, the samples were extracted from normal tissues affected by 
nonruptured aneurisms in patients who were different from the patients exhibiting 
malignant brain tumors. The results show that the method may be adapted, after further 
experimental in vitro tests, to real-time intraoperative conditions by measuring the 
autofluorescence of the tumor and of the adjacent normal tissue; to do that, it is first 
necessary to consider the effect of tumor pressure on the molecular content and structure of 
the adjacent normal tissues. Because real-time investigation does not require tissue 
extraction, the method could be acceptable to the ethics bodies supervising neurosurgical 
operations; intraoperative fluorescence guidance for resection of malignant tumors is 
currently receiving more clinical interest both for imaging purposes (Kantelhardt et al., 
2007) and for fast intraoperative diagnostics (Croce et al., 2003; Kremer et al., 2009). The 
results reported in this paper demonstrate that for neurosurgical clinical use of 
autofluorescence measurements, the following precautions should be taken: (a) the 
autofluorescence measurements, either in vitro or in vivo, should be made using tissue 
pairs: normal/malignant tumor; (b) the contribution of any anesthetic to the measured 
autofluorescence should always be evaluated, to avoid unexpected interference with the 
natural autofluorescence of the tissues and errors in data interpretation; the fluorescence 
emitted by exogenous fluorophores which might be present in the brain area submitted to 
autofluorescence screening should also be carefully evaluated; (c) in obtaining the 
autofluorescence spectra, the optimal intensity of the laser excitation beam should be chosen 
to prevent both damage to the brain tissues and the quadratic Stark broadening of the 
absorption and fluorescence bands; the latter might induce errors in the accurate 
measurement of the peak wavelengths and of the overall fluorescence bands.  
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The focus of the book Diagnostic Techniques and Surgical Management of Brain Tumors is on describing the
established and newly-arising techniques to diagnose central nervous system tumors, with a special focus on
neuroimaging, followed by a discussion on the neurosurgical guidelines and techniques to manage and treat
this disease. Each chapter in the Diagnostic Techniques and Surgical Management of Brain Tumors is
authored by international experts with extensive experience in the areas covered.
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